SCHEMBL24026602

SCHEMBL24026602

CC1(C)OB(c2ccc(Cl)c3c2[nH]c2ccccc23)OC1(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ GABRP O00591 2/20 0.39
▸ GABRD O14764 2/20 0.39
▸ GABRA1 P14867 2/20 0.39
▸ GABRB1 P18505 2/20 0.39
▸ GABRG2 P18507 2/20 0.39
▸ GABRB3 P28472 2/20 0.39
▸ GABRA5 P31644 2/20 0.39
▸ GABRA3 P34903 2/20 0.39
▸ GABRA2 P47869 2/20 0.39
▸ GABRB2 P47870 2/20 0.39
▸ GABRA4 P48169 2/20 0.39
▸ GABRE P78334 2/20 0.39
▸ GABRA6 Q16445 2/20 0.39
▸ GABRG1 Q8N1C3 2/20 0.39
▸ GABRG3 Q99928 2/20 0.39
▸ GABRQ Q9UN88 2/20 0.39
▸ CDK4 P11802 4/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20857933 0.82 MEN1 (0.49) MEN1MAPTKMT2AGABRPGABRD
SCHEMBL20857944 0.81 DYRK1A (0.48) MEN1MAPTKMT2AGABRPGABRD
SCHEMBL22787320 0.80 KIF11 (0.38) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL28820800 0.80 GABRP (0.40) MEN1MAPTKMT2AGABRPGABRD
SCHEMBL29675284 0.79 KIF11 (0.49) MEN1MAPTKMT2AGABRPGABRD
SCHEMBL16835585 0.79 KIF11 (0.49) MEN1MAPTKMT2AGABRPGABRD
SCHEMBL29961225 0.79 KIF11 (0.49) MEN1MAPTKMT2AGABRPGABRD
SCHEMBL24564215 0.78 DYRK1A (0.42) MEN1MAPTKMT2AGABRPGABRD
SCHEMBL5102925 0.76 LPL (0.40) MEN1MAPTKMT2AGABRPGABRD
SCHEMBL30825642 0.76 IMPDH2 (0.45) MEN1MAPTKMT2AGABRPGABRD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230039299-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-02-09 — — US disclosed
US-20210359221-A1 COMPOUND, AND ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS USING THE SAME IDEMITSU KOSAN CO.,LTD. (JP) 2021-11-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230039299-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE PIEZO1, OR10J3, RER1 MEN1 159/4885MAPT 3189/4885KMT2A 2987/4885
US-20210359221-A1 COMPOUND, AND ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS USING THE SAME HAX1, AFF4, XPO4 MEN1 825/4885MAPT 3234/4885KMT2A 1890/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback